MedKoo Cat#: 527305 | Name: LGD-2941

Description:

WARNING: This product is for research use only, not for human or veterinary use.

LGD-2941 is an androgen receptor modulator for the treatment of hypogonadism, female sexual dysfunction and menopausal syndrome. It had also been used to treat osteoporosis in early clinical trials.

Chemical Structure

LGD-2941
LGD-2941
CAS#847235-85-2

Theoretical Analysis

MedKoo Cat#: 527305

Name: LGD-2941

CAS#: 847235-85-2

Chemical Formula: C17H16F6N2O2

Exact Mass: 394.1116

Molecular Weight: 394.32

Elemental Analysis: C, 51.78; H, 4.09; F, 28.91; N, 7.10; O, 8.11

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
LGD-2941; LGD 2941; LGD2941
IUPAC/Chemical Name
6-((2R,5R)-2-methyl-5-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-4-(trifluoromethyl)quinolin-2(1H)-one
InChi Key
HWLLYFXDDGGHOE-BCSUUIJWSA-N
InChi Code
InChI=1S/C17H16F6N2O2/c1-8-2-5-13(15(27)17(21,22)23)25(8)9-3-4-12-10(6-9)11(16(18,19)20)7-14(26)24-12/h3-4,6-8,13,15,27H,2,5H2,1H3,(H,24,26)/t8-,13-,15-/m1/s1
SMILES Code
O=C1NC2=C(C=C(N3[C@H](C)CC[C@@H]3[C@@H](O)C(F)(F)F)C=C2)C(C(F)(F)F)=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
LGD-2941 is an androgen receptor modulator for the treatment of hypogonadism, female sexual dysfunction and menopausal syndrome.
In vitro activity:
TBD
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 394.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Riedmaier I, Tichopad A, Reiter M, Pfaffl MW, Meyer HH. Influence of testosterone and a novel SARM on gene expression in whole blood of Macaca fascicularis. J Steroid Biochem Mol Biol. 2009 Apr;114(3-5):167-73. doi: 10.1016/j.jsbmb.2009.01.019. PubMed PMID: 19429447. 2: Reiter M, Tichopad A, Riedmaier I, Pfaffl MW, Meyer HH. Monitoring gene expression in muscle tissue of macaca fascicularis under the influence of testosterone and SARM. Horm Mol Biol Clin Investig. 2010 Jan 1;1(2):73-9. doi: 10.1515/HMBCI.2010.007. PubMed PMID: 25961973. 3: Furuya K. [Bone and Men's Health. Bone selective androgen receptor modulators]. Clin Calcium. 2010 Feb;20(2):225-33. doi: CliCa1002225233. Review. Japanese. PubMed PMID: 20118515. 4: Martinborough E, Shen Y, Oeveren Av, Long YO, Lau TL, Marschke KB, Chang WY, López FJ, Vajda EG, Rix PJ, Viveros OH, Negro-Vilar A, Zhi L. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators. J Med Chem. 2007 Oct 18;50(21):5049-52. PubMed PMID: 17887661.